- Home
- EQS vs COSM Comparison
EQS vs COSM Comparison
Compare EQS & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQS
- COSM
- Stock Information
- Founded
- EQS 1991
- COSM 2009
- Country
- EQS United States
- COSM United States
- Employees
- EQS N/A
- COSM N/A
- Industry
- EQS Finance Companies
- COSM Other Pharmaceuticals
- Sector
- EQS Finance
- COSM Health Care
- Exchange
- EQS Nasdaq
- COSM Nasdaq
- Market Cap
- EQS 17.0M
- COSM 18.4M
- IPO Year
- EQS N/A
- COSM 2013
- Fundamental
- Price
- EQS $1.37
- COSM $0.62
- Analyst Decision
- EQS
- COSM
- Analyst Count
- EQS 0
- COSM 0
- Target Price
- EQS N/A
- COSM N/A
- AVG Volume (30 Days)
- EQS 3.4K
- COSM 397.6K
- Earning Date
- EQS 01-01-0001
- COSM 11-14-2024
- Dividend Yield
- EQS N/A
- COSM N/A
- EPS Growth
- EQS N/A
- COSM N/A
- EPS
- EQS N/A
- COSM N/A
- Revenue
- EQS $1,137,000.00
- COSM $56,042,109.00
- Revenue This Year
- EQS N/A
- COSM $4.53
- Revenue Next Year
- EQS N/A
- COSM $25.00
- P/E Ratio
- EQS N/A
- COSM N/A
- Revenue Growth
- EQS 1795.00
- COSM 13.01
- 52 Week Low
- EQS $1.01
- COSM $0.47
- 52 Week High
- EQS $1.63
- COSM $1.58
- Technical
- Relative Strength Index (RSI)
- EQS 58.36
- COSM 40.41
- Support Level
- EQS $1.26
- COSM $0.60
- Resistance Level
- EQS $1.43
- COSM $0.67
- Average True Range (ATR)
- EQS 0.05
- COSM 0.07
- MACD
- EQS -0.00
- COSM -0.01
- Stochastic Oscillator
- EQS 69.29
- COSM 6.77
About EQS Equus Total Return Inc.
Equus Total Return Inc is a United States-based closed-end management investment company. It invest primarily in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts and recapitalizations of existing businesses or special situations and achieve capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.